JP2024535845A5 - - Google Patents
Info
- Publication number
- JP2024535845A5 JP2024535845A5 JP2024516797A JP2024516797A JP2024535845A5 JP 2024535845 A5 JP2024535845 A5 JP 2024535845A5 JP 2024516797 A JP2024516797 A JP 2024516797A JP 2024516797 A JP2024516797 A JP 2024516797A JP 2024535845 A5 JP2024535845 A5 JP 2024535845A5
- Authority
- JP
- Japan
- Prior art keywords
- arg
- pharmaceutical preparation
- approximately
- peptide
- trp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163245770P | 2021-09-17 | 2021-09-17 | |
| US63/245,770 | 2021-09-17 | ||
| US17/730,042 US20230106943A1 (en) | 2021-09-17 | 2022-04-26 | Engineered antimicrobial peptides and usage thereof |
| US17/730,042 | 2022-04-26 | ||
| PCT/US2022/076421 WO2023044339A1 (en) | 2021-09-17 | 2022-09-14 | Engineered antimicrobial peptides and usage thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024535845A JP2024535845A (ja) | 2024-10-02 |
| JP2024535845A5 true JP2024535845A5 (cg-RX-API-DMAC10.html) | 2026-01-21 |
Family
ID=85603598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516797A Pending JP2024535845A (ja) | 2021-09-17 | 2022-09-14 | 操作された抗微生物ペプチドおよびその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20230106943A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4401754A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024535845A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022345264A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3231957A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023044339A1 (cg-RX-API-DMAC10.html) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030036627A1 (en) * | 2001-02-16 | 2003-02-20 | Montelaro Ronald C. | Virus derived antimicrobial peptides |
| WO2008070083A2 (en) * | 2006-12-04 | 2008-06-12 | Keybay Pharma, Inc. | Filter media using peptide-based antimicrobials |
| RS60101B1 (sr) * | 2008-08-15 | 2020-05-29 | Ironwood Pharmaceuticals Inc | Formulacije koje sadrže linaklotid za oralnu primenu |
| US8530409B1 (en) * | 2012-06-12 | 2013-09-10 | Dipexium Pharmaceuticals LLC | Stable pexiganan formulation |
| US11236314B2 (en) * | 2017-03-30 | 2022-02-01 | Bactoclear Holdings Pte. Ltd | Chimeric lysm polypeptides |
| WO2019089657A1 (en) * | 2017-10-30 | 2019-05-09 | Allvivo Vascular, Inc. | Delivery systems for administration of cationic biological actives |
| US20220249599A1 (en) * | 2018-03-13 | 2022-08-11 | Peptilogics, Inc. | Treatment of implants with engineered antimicrobial amphiphilic peptides |
| JP2023501385A (ja) * | 2019-11-08 | 2023-01-18 | ユニバーシティ オブ ピッツバーグ － オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 抗微生物ペプチドを含む組成物 |
| EP4401752A4 (en) * | 2021-09-17 | 2025-07-16 | Peptilogics Inc | MODIFIED ANTIMICROBIAL PEPTIDES AND THEIR USE |
-
2022
- 2022-04-26 US US17/730,042 patent/US20230106943A1/en not_active Abandoned
- 2022-09-14 JP JP2024516797A patent/JP2024535845A/ja active Pending
- 2022-09-14 WO PCT/US2022/076421 patent/WO2023044339A1/en not_active Ceased
- 2022-09-14 AU AU2022345264A patent/AU2022345264A1/en active Pending
- 2022-09-14 CA CA3231957A patent/CA3231957A1/en active Pending
- 2022-09-14 EP EP22870924.2A patent/EP4401754A4/en active Pending
-
2025
- 2025-03-06 US US19/072,538 patent/US20250195611A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2007238114B2 (en) | Rapid acting and long acting insulin combination formulations | |
| ES2253774T3 (es) | Formulacion farmaceutica conteniendo hormona de crecimiento humana, histidina y un detergente no ionico. | |
| JP2024099628A5 (cg-RX-API-DMAC10.html) | ||
| ES2391776T3 (es) | Formulaciones solubles, estables conteniendo insulina con una sal de protamina | |
| CN101272764B (zh) | hFSH水制剂 | |
| US6150331A (en) | Human growth hormone-containing aqueous pharmaceutical composition | |
| JP2010509308A (ja) | ペプチド及び関連化合物の経皮送達システム | |
| RU2605288C2 (ru) | Фармацевтическая композиция | |
| GB2112641A (en) | The use of peptides as medicaments | |
| ES2275276T3 (es) | Procedimiento de administracion de igf - i. | |
| JP4053586B2 (ja) | ガンマインターフェロンの安定液体組成物 | |
| JP2024536768A5 (cg-RX-API-DMAC10.html) | ||
| US20250090622A1 (en) | Angiotensin compositions and methods related thereto | |
| RU2013128357A (ru) | Стабильный готовый к применению инъекционный раствор цетрореликса | |
| US20050074485A1 (en) | Anti-inflammatory/anti-microbial peptides for use in dialysis | |
| KR100271671B1 (ko) | 고농도 tcf 주사제 | |
| WO2017183559A1 (ja) | 薬物の経粘膜吸収促進剤 | |
| KR101838759B1 (ko) | 점안제 | |
| JPH0338255B2 (cg-RX-API-DMAC10.html) | ||
| ES2358018T3 (es) | Uso de compuestos de kahalalida para la fabricación de un medicamento para el tratamiento de la psoriasis. | |
| CN102440957B (zh) | 醋酸特利加压素鼻腔喷雾剂及其制备方法 | |
| JP3002725B2 (ja) | 線維芽細胞増殖因子関連ペプチドからなる医薬組成物 | |
| JPH07503705A (ja) | 医薬的リジン含有ポリペプチド組成物およびその使用法 | |
| JP6179939B2 (ja) | 高濃度γグロブリン製剤の粘度低下方法 | |
| JPS63303931A (ja) | 経鼻投与用成長ホルモン放出活性物質製剤 |